Purchase Order 15BCTS24P00000013

Award Date 4/5/24
Potential Completion Date 8/29/24
Potential Value $2.7K
Federal Agency
Central Office
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Manchester, NH 03101, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Justice's Bureau of Prisons awarded a firm fixed price purchase order worth $5,092.00 to Acadia Healthcare Company, Inc. to provide medication-assisted treatment (MAT) services for opioid addiction at an opioid treatment program (OTP) in Wilmington, Delaware. The contract has a completion date of August 28, 2024. Acadia Healthcare is a for-profit healthcare services provider that has previously received federal contracts and sub-awards to deliver substance abuse treatment...
This is a firm-fixed-price purchase order awarded by the Central Office, a civilian agency, to Acadia Healthcare Company, Inc. for Medication-Assisted Treatment (MAT) services at an Opioid Treatment Program (OTP) in Boston, MA. The contract has a ceiling value of $19,485.00 and a completion date of September 30, 2025. The contract was awarded on March 13, 2025 and does not utilize a set-aside designation. Acadia Healthcare Company, Inc. is a for-profit healthcare services provider specializing...
This is a firm-fixed-price purchase order awarded to Acadia Healthcare Company, Inc. by the Central Office of the U.S. Department of Health and Human Services (HHS) to provide medication-assisted treatment (MAT) at an opioid treatment program (OTP) in Baltimore, Maryland. The contract has a ceiling value of $1,406.00 and a completion date of April 11, 2024. The award was made on March 6, 2024, and there is no set-aside designation. Acadia Healthcare is a for-profit healthcare services provider...
This federal contract award to Acadia Healthcare Company, Inc., doing business as Acadia Healthcare, is for the provision of Medication-Assisted Treatment (MAT) services at an Opioid Treatment Program (OTP) in Clarksburg, West Virginia. The contract is a firm-fixed-price purchase order with a ceiling value of $1,800 and an ultimate completion date of March 13, 2024. The award was made by the Central Office, a civilian agency within the federal government. Acadia Healthcare is a for-profit...
The U.S. government has awarded a firm-fixed-price purchase order contract to Colonial Management Group, L.P. for the provision of medication-assisted treatment (MAT) services at an opioid treatment program (OTP) located in Roseville, Minnesota. The contract has a ceiling value of $2,530 and an ultimate completion date of June 19, 2024. No set-aside designation was used for this award. The contracting agency is the Federal Bureau of Prisons, which is part of the U.S. Department of Justice....
This firm fixed price purchase order awards Pinnacle Treatment Centers, Inc. $3,560 to provide medication-assisted treatment (MAT) at an opioid treatment program (OTP) in Macon, Georgia. The Department of Justice Bureau of Prisons Central Office issued this contract to deliver MAT services through March 2024 at a place of performance in Mount Laurel, New Jersey. No set-aside designation applies. Pinnacle will utilize its OTP facility and staff to administer medications like methadone or...
The U.S. Department of Justice's Bureau of Prisons awarded a firm fixed price delivery order to McKesson Corporation, a healthcare services and information technology company, for the provision of medications for Medication-Assisted Treatment (MAT) programs at two federal correctional facilities. The award, valued at $219,497.16, covers the delivery of pharmaceutical products from January through September 2024. This delivery order was issued against an existing indefinite delivery/indefinite...
This federal contract award was issued by the Department of Justice's Bureau of Prisons (BOP) to the prime contractor Mckesson Corporation, doing business as Mckesson, for the provision of MAT (Medication-Assisted Treatment) medications. The $1,051,811.07 firm fixed price delivery order has an ultimate completion date of September 12, 2024 and was awarded on October 1, 2023. Mckesson is a healthcare services and information technology company that provides pharmaceuticals, medical supplies,...
This federal contract award is for a Delivery Order issued by the Federal Correctional Institution Loretto, part of the Department of Justice's Bureau of Prisons, to Mckesson Corporation, a for-profit healthcare services and IT company, for the provision of Medication Assisted Treatment (MAT) medications with a ceiling value of $14,000.00. The contract has a firm fixed price pricing type and an ultimate completion date of March 31, 2025. No set-aside designation was used. This Delivery Order...
This is a firm fixed-price delivery order awarded to Wellpath LLC, doing business as Recovery Solutions, by the Federal Bureau of Prisons to provide Medication Assisted Treatment (MAT) services nationwide. The $9,661,250.00 contract has an ultimate completion date of September 30, 2025. Wellpath, a for-profit limited liability company, is an experienced provider of comprehensive healthcare services to correctional facilities, including medical, dental, behavioral health, pharmacy, and telehealth...

This $2,692.65 firm-fixed-price purchase order was awarded by the Central Office of the U.S. Department of Justice's Bureau of Prisons to Acadia Healthcare Company, Inc. to provide medication-assisted treatment (MAT) services at an opioid treatment program (OTP) facility located in Manchester, New Hampshire. The contract does not utilize any set-aside designations and has an ultimate completion date of August 29, 2024. Acadia Healthcare Company, Inc., a for-profit behavioral health and addiction treatment services provider, has received multiple prior federal contract and grant awards to deliver substance abuse treatment, particularly opioid substitution therapy and MAT, at various facilities across the United States. This contract award is part of the agency's efforts to provide comprehensive opioid treatment services, including medication, counseling, drug screening, and medical services, to address the opioid crisis.

Generated 9/13/24, 9:02 AM